Nine studies evaluated ki-67 as a prognostic marker in relation to overall survival (alternatively: disease-specific survival, with causes of death other than vulvar carcinoma excluded) and/or progression-free survival; refer to Table 2 for a comprehensive overview of study details. The gene discussed is MKI67; the disease is vulvar carcinoma.